Deal Watch: Teva's Sol Barer Leads Buyout Of IO Start-up NexImmune

 
• By Joseph Haas, Ian Haydock, Ying Huang, John Davis, and Sten Stovall
DealWatch_1200x675

More from Business

More from Scrip